The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease

被引:29
作者
Dunn, CS [1 ]
Samuel, AR [1 ]
Pullen, LA [1 ]
Anderson, J [1 ]
机构
[1] AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England
关键词
D O I
10.1006/viro.1998.9175
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Five neutralisation epitopes have been defined for the O-1 Kaufbeuren strain of foot-and-mouth disease virus (FMDV) by neutralising murine monoclonal antibodies (Mabs). A mutant virus which is resistant to all these Mabs also resists neutralisation by bovine polyclonal sera, and this characteristic was exploited in the current study to investigate the biological relevance of neutralisation sites in FMDV virulence and vaccine protection. The five site neutralisation-resistant mutant was shown to be as pathogenic as wild-type virus in the guinea pig model of FMD. Guinea pigs were protected in cross-challenge studies from virulent wild-type and mutant viruses using either wild-type or mutant 146S antigen as inactivated whole virus vaccine. Furthermore, hyperimmune sera raised to either wild-type or mutant antigen offered passive protection against wild-type challenge, in spite of the serum raised against the mutant antigen having minimal neutralising activity in vitro. These results imply that virus neutralisation, at least as defined by the in vitro assay, may not play an essential role in the mechanism of immunity induced by whole inactivated FMDV vaccines. (C) 1998 Academic Press.
引用
收藏
页码:51 / 61
页数:11
相关论文
共 72 条
[1]   ENZYME-LABELED IMMUNOSORBENT ASSAY TECHNIQUES IN FOOT-AND-MOUTH-DISEASE VIRUS RESEARCH [J].
ABUELZEIN, EME ;
CROWTHER, JR .
JOURNAL OF HYGIENE, 1978, 80 (03) :391-399
[2]   THE 3-DIMENSIONAL STRUCTURE OF FOOT-AND-MOUTH-DISEASE VIRUS AT 2.9-A RESOLUTION [J].
ACHARYA, R ;
FRY, E ;
STUART, D ;
FOX, G ;
ROWLANDS, D ;
BROWN, F .
NATURE, 1989, 337 (6209) :709-716
[3]   BINARY ETHYLENIMINE AS AN INACTIVANT FOR FOOT-AND-MOUTH-DISEASE VIRUS AND ITS APPLICATION FOR VACCINE PRODUCTION [J].
BAHNEMANN, HG .
ARCHIVES OF VIROLOGY, 1975, 47 (01) :47-56
[4]   INACTIVATION OF VIRAL-ANTIGENS FOR VACCINE PREPARATION WITH PARTICULAR REFERENCE TO THE APPLICATION OF BINARY ETHYLENIMINE [J].
BAHNEMANN, HG .
VACCINE, 1990, 8 (04) :299-303
[5]   PROTECTION AGAINST LETHAL CHALLENGE OF BALB/C MICE BY PASSIVE TRANSFER OF MONOCLONAL-ANTIBODIES TO 5 GLYCOPROTEINS OF HERPES-SIMPLEX VIRUS TYPE-2 [J].
BALACHANDRAN, N ;
BACCHETTI, S ;
RAWLS, WE .
INFECTION AND IMMUNITY, 1982, 37 (03) :1132-1137
[6]   T-LYMPHOCYTE RESPONSES IN GUINEA-PIGS VACCINATED WITH FOOT-AND-MOUTH-DISEASE VIRUS [J].
BARTELS, T ;
SCHAFER, H ;
LIEBERMANN, H ;
BURGER, R ;
BEYER, J .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 40 (03) :213-223
[7]   MECHANISMS OF MONOCLONAL ANTIBODY-MEDIATED PROTECTION AGAINST VIRULENT SEMLIKI FOREST VIRUS [J].
BOERE, WAM ;
BENAISSATROUW, BJ ;
HARMSEN, T ;
ERICH, T ;
KRAAIJEVELD, CA ;
SNIPPE, H .
JOURNAL OF VIROLOGY, 1985, 54 (02) :546-551
[8]   A HIGHLY DIVERGENT ANTIGENIC SITE OF FOOT-AND-MOUTH-DISEASE VIRUS RETAINS ITS IMMUNODOMINANCE [J].
BORREGO, B ;
CAMARERO, JA ;
MATEU, MG ;
DOMINGO, E .
VIRAL IMMUNOLOGY, 1995, 8 (01) :11-18
[9]   NEW APPROACHES TO VACCINATION AGAINST FOOT-AND-MOUTH-DISEASE [J].
BROWN, F .
VACCINE, 1992, 10 (14) :1022-1026
[10]   NUCLEOTIDE CHANGES RESPONSIBLE FOR LOSS OF NEUROINVASIVENESS IN JAPANESE ENCEPHALITIS-VIRUS NEUTRALIZATION-RESISTANT MUTANTS [J].
CECILIA, D ;
GOULD, EA .
VIROLOGY, 1991, 181 (01) :70-77